SSX2IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.130600E-01
Normal-vs-Stage2
9.675000E-01
Normal-vs-Stage3
1.421960E-01
Normal-vs-Stage4
2.490600E-01
Stage1-vs-Stage2
2.084400E-01
Stage1-vs-Stage3
1.522160E-01
Stage1-vs-Stage4
3.134600E-01
Stage2-vs-Stage3
2.783400E-01
Stage2-vs-Stage4
1.907420E-01
Stage3-vs-Stage4
3.568500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.297800E-01
Normal-vs-AfricanAmerican
2.480200E-01
Normal-vs-Asian
7.728000E-01
Caucasian-vs-AfricanAmerican
1.855950E-01
Caucasian-vs-Asian
4.464200E-01
AfricanAmerican-vs-Asian
4.705800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.661800E-01
Normal-vs-Female
7.752800E-01
Male-vs-Female
4.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.209200E-01
Normal-vs-Age(41-60Yrs)
5.716800E-01
Normal-vs-Age(61-80Yrs)
9.742400E-01
Normal-vs-Age(81-100Yrs)
6.443800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.626800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.227000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.989400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.743900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.945800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.513000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.757400E-01
Normal-vs-Daily Drinker
1.952630E-01
Normal-vs-Weekly Drinker
6.471400E-01
Normal-vs-Occasional Drinker
6.091400E-01
Normal-vs-Social Drinker
6.802200E-01
Non Drinker-vs-Daily Drinker
2.492200E-01
Non Drinker-vs-Weekly Drinker
9.919800E-01
Non Drinker-vs-Occasional Drinker
1.110600E-01
Non Drinker-vs-Social Drinker
1.834600E-01
Daily Drinker-vs-Weekly Drinker
2.659800E-01
Daily Drinker-vs-Occasional Drinker
3.923900E-02
Daily Drinker-vs-Social Drinker
6.361900E-02
Weekly Drinker-vs-Occasional Drinker
1.206780E-01
Weekly Drinker-vs-Social Drinker
1.987380E-01
Occasional Drinker-vs-Social Drinker
7.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.200600E-01
Normal-vs-Grade 2
4.467000E-01
Normal-vs-Grade 3
4.282200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.925220E-01
Grade 1-vs-Grade 3
1.711400E-01
Grade 1-vs-Grade 4
5.200600E-01
Grade 2-vs-Grade 3
8.194800E-01
Grade 2-vs-Grade 4
4.467000E-01
Grade 3-vs-Grade 4
4.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.777200E-01
Normal-vs-NonDiabetic
8.583200E-01
Diabetic-vs-NonDiabetic
1.368630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.014800E-01
Normal-vs-NoPancreatitis
8.890600E-01
Pancreatitis-vs-NoPancreatitis
5.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.259600E-01
Normal-vs-N1
9.597400E-01
N0-vs-N1
4.945900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.832200E-01
Normal-vs-TP53-NonMutant
5.608000E-02
TP53-Mutant-vs-TP53-NonMutant
4.103100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
